We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.78B
AUM Growth
–
Cap. Flow
+$4.65B
Cap. Flow
% of AUM
97.21%
Top 10 Holdings %
Top 10 Hldgs %
14.27%
Holding
616
New
605
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$91.9M |
| 2 |
CELG
Celgene Corp
CELG
|
+$79.7M |
| 3 |
Apple
AAPL
|
+$78.2M |
| 4 |
Qualcomm
QCOM
|
+$73.5M |
| 5 |
Amgen
AMGN
|
+$71.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 14.02% |
| 3 | Technology | 12.7% |
| 4 | Industrials | 8.01% |
| 5 | Energy | 6.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
American Electric Power
AEP
$73.7B
| $14.5M | 0.3% |
+239,443
| New | +$13.7M |
|
|
LLTC
102
DELISTED
Linear Technology Corp
LLTC
| $14.3M | 0.3% |
+314,396
| New | +$13.7M |
|
103
Masco
MAS
$16B
| $14.3M | 0.3% |
+645,582
| New | +$13.3M |
|
104
Lincoln National
LNC
$7.91B
| $14.1M | 0.29% |
+244,467
| New | +$13.3M |
|
105
Cintas
CTAS
$82.4B
| $14M | 0.29% |
+715,040
| New | +$12.9M |
|
106
Credicorp
BAP
$30.9B
| $14M | 0.29% |
+87,200
| New | +$13.8M |
|
|
BCR
107
DELISTED
CR Bard Inc.
BCR
| $13.9M | 0.29% |
+83,704
| New | +$13.5M |
|
108
iShares US Real Estate ETF
IYR
$4.59B
| $13.8M | 0.29% |
+179,888
| New | +$13.5M |
|
109
PepsiCo
PEP
$186B
| $13.7M | 0.29% |
+145,421
| New | +$13.9M |
|
110
Brookfield
BN
$102B
| $13.7M | 0.29% |
+1,166,454
| New | +$13.1M |
|
111
Genuine Parts
GPC
$17.1B
| $13.6M | 0.29% |
+128,033
| New | +$12.5M |
|
112
Emerson Electric
EMR
$82.9B
| $13.3M | 0.28% |
+215,750
| New | +$13.5M |
|
113
EQT Corp
EQT
$33.2B
| $13.3M | 0.28% |
+321,754
| New | +$15.2M |
|
114
Unum
UNM
$13.8B
| $13M | 0.27% |
+372,762
| New | +$12.6M |
|
115
Abbott
ABT
$180B
| $12.8M | 0.27% |
+285,453
| New | +$12.4M |
|
116
Fluor
FLR
$7.29B
| $12.7M | 0.27% |
+209,790
| New | +$13.3M |
|
117
Canadian Imperial Bank of Commerce
CM
$107B
| $12.6M | 0.26% |
+296,170
| New | +$13.1M |
|
118
Progressive
PGR
$124B
| $12.6M | 0.26% |
+465,278
| New | +$12.3M |
|
119
Texas Instruments
TXN
$255B
| $12.5M | 0.26% |
+233,550
| New | +$11.8M |
|
120
Dover
DOV
$27.2B
| $12.5M | 0.26% |
+215,361
| New | +$13.4M |
|
121
Sherwin-Williams
SHW
$78.3B
| $12.4M | 0.26% |
+141,021
| New | +$11.1M |
|
122
Hershey
HSY
$35.4B
| $12.4M | 0.26% |
+118,858
| New | +$11.6M |
|
123
Xcel Energy
XEL
$51B
| $12.3M | 0.26% |
+342,985
| New | +$11.5M |
|
124
NOV
NOV
$7.45B
| $11.9M | 0.25% |
+180,929
| New | +$12.6M |
|
|
NBL
125
DELISTED
Noble Energy, Inc.
NBL
| $11.8M | 0.25% |
+249,261
| New | +$13.5M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q4 2014 Portfolio in Review
Q4 2014 is the first quarter with a 13F filing on record for Candriam SCA, which disclosed 616 positions worth $4.78B. Its ten largest holdings account for 14% of the portfolio.
Its largest position is Gilead Sciences: 888,125 shares worth $83.7M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Technology.
- Candriam SCA's largest Q4 2014 buy was Gilead Sciences: 888,125 shares worth $83.7M.
- Candriam SCA's ten largest holdings make up 14% of its $4.78B portfolio in Q4 2014.
- Candriam SCA disclosed 616 positions in Q4 2014, its first 13F filing on record.
Based on Candriam SCA's 13F filing for Q4 2014, filed 26 Mar 2015.